The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Now going toe to toe with Lynparza!
Dr G is a dab hand at these RNS’s
"This work will direct and support future out-licensing discussions for NXP004. I look forward to providing further updates in due course as we progress."
So have they even spoken to AZ yet or are we now looking to open discussions with the competition because they haven't come to the table?
Thanks Julian, you are doing a good job already.
FX, they haven’t spoke to anyone commercially, the previous announcements always said it would be after patent is granted.
FX future talks could mean continuation, there is no doubt Merck has been speaking to someone as their CEO talks about formulation and delivery of Lynparza and extending their control into the next decade in the attached interview quite a few parallels
https://tradetoday.co.in/merck-co-inc-mrk-ceo-rob-davis-presents-at-the-goldman-sachs-43rd-annual-global-healthcare-conference-transcript/
And there we have the separate 004 update as I'd hoped, all looking good apart from the SP and clarity around management going forward, it's a steal as they say
Who is doing the 1 trades? Bang on twice now, not followed by any serious buying though.
Again another positive RNS ... Looks like the company is trying to get a positive message out ... LH&K Mafuta
It’s almost like they can operate without a chairman ;-)
But can they get the share price moving without a Chairman?
Have a hunch we will get an NXP001 update shortly - Friday?
As long as any prospective chairman moves the sp in the opposite direction to where AR was taking it then I don’t mind.
Agreed.
It just goes to show what a positive mindset can achieve with the same material, AR's 30 May RNS was very negative & failed to highlight the positive, now we have the reverse - there is hope (rational hope that is).
Doesn’t help when the PR company hired by Riddell are so incompetent they can’t even get the right product on their announcement tweet.
And he also got rid of Allenby, who actually produced a useful & informative research product - considerably better than the usual pap that comes out of smaller company brokers.
What is going on we have ano 1 buy already
Good buying volume again.
Mars1, I think that’s Mulder & ATrades going halfers, and buying in ;-)
Indeed chab, lots refusing to move the bid up, which means some traders have been rinsed already this morning.
And for a while top of the LSE Share Risers - been some time since we did that.
As always, the time to buy was last week, when most were whining, moaning and wetting their pants.
Might be a big jump bit the sell price is staying low. A big split in the buy/sell price
What is interesting in the Merck CEO interview was he said further negotiations were expected later this year
Buying stalled. They'll need to close that spread to attract more buyers. A few fingers burnt?
Going to be the test now, punters who bought this morning now facing the choice of whether to hold or not. Someone just sold their 421k three hours after buying it at 0.47